Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi, SA Mousavi… - … and Apheresis Science, 2020 - Elsevier
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …

Exploring lectin–glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses

LC Nascimento da Silva, JSP Mendonça… - …, 2021 - academic.oup.com
The emergence of a new human coronavirus severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has imposed great pressure on the health system worldwide …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания: на перекрестке проблем тромбовоспаления и …

ЕЛ Насонов, ТВ Бекетова, ТМ Решетняк… - Научно …, 2020 - cyberleninka.ru
Воспаление и свертывание крови составляют основу защиты организма от
потенциально патогенных механических и биологических воздействий внешней и …

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

E Nasonov, T Beketova, T Reshetnyak, A Lila… - 2021 - covid19.neicon.ru
Inflammation and coagulation are key basic mechanism of protection against all potentially
pathogenic mechanical and biological factors targeting human organism from inner and …

Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices

GK Patidar, KJ Land, H Vrielink… - Vox …, 2021 - Wiley Online Library
Background and objectives Cytokine release syndrome in COVID‐19 is due to a
pathological inflammatory response of raised cytokines. Removal of these cytokines by …

Membrane-based therapeutic plasma exchange in intensive care

S Redant, D De Bels, K Ismaili, PM Honoré - Blood Purification, 2021 - karger.com
Membrane-Based Therapeutic Plasma Exchange in Intensive Care | Blood Purification | Karger
Publishers Skip to Main Content S. Karger AG S. Karger AG Close Who We Serve Who We …

The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence

W Lu, W Kelley, DC Fang, S Joshi, Y Kim… - Journal of clinical …, 2021 - Wiley Online Library
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a major
pandemic. While vaccine development moves forward, optimal treatment continues to be …

[HTML][HTML] The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran

S Kalantari, A Sadeghzadeh-Bazargan… - Medical Journal of the …, 2021 - ncbi.nlm.nih.gov
Background: The COVID-19 infection is a novel virus that mainly targets the respiratory
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …

On therapeutic plasma exchange against severe COVID-19-associated pneumonia: an observational clinical study

L Cegolon, B Einollahi, Y Panahi, S Imanizadeh… - Frontiers in …, 2022 - frontiersin.org
Background There is a risk of novel mutations of SARS-CoV-2 that may render COVID-19
resistant to most of the therapies, including antiviral drugs and vaccines. The evidence …

[HTML][HTML] Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection

A Sadeghi, S Sadeghi, MS Peikar, M Yazdi… - Blood …, 2023 - synapse.koreamed.org
Background With the emergence of the coronavirus disease 2019 (COVID-19) and inability
of healthcare systems to control the disease, various therapeutic theories with controversial …